Skip to content

Traditional Chinese medicine injection for pandemic influenza A(H1N1) cases of serious condition: a prospective, multicentre, pragmatic randomized loading controlled trial

Traditional Chinese medicine injection for pandemic influenza A(H1N1) cases of serious condition: a prospective, multicentre, pragmatic randomized loading controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000814
Enrollment
Unknown
Registered
2010-02-02
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pandemic influenza A(H1N1) cases of serious condition

Interventions

Trial group:traditional Chinese medicine injection combined wi
Trial group :traditional Chinese medicine injection combined with routine western medicine treatment: application of Reduling Injection, Xiyanping Injection and Danshen Injection according to TCM syn
Total :NA

Sponsors

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Meet with the diagnostic standard of pandemic influenza A(H1N1) cases of serious condition including suspected cases, clinical diagnosis cases, confirmed cases, and belonging to toxic heat obstructing lung syndromes; (2) age: 6 and over; (3) patients or their guardians agree to participate in randomized controlled trials and signed the informed consent

Exclusion criteria

Exclusion criteria: (1) patients with unstable psychiatric disorder; (2) patients with allergic constitution.

Design outcomes

Primary

MeasureTime frame
fever clearance time;conversion of critical condition;length of sta;

Secondary

MeasureTime frame
symptoms;safety outcomes;clearance time and negative rate of pandemic influ;direct medical cost;APACHE II scores;the days and parameter variation of respirator uti;incidence of complication;

Countries

China

Contacts

Public ContactWang Zhong
zhonw@vip.sina.com01064014411-3308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026